CClinicalTrials.gg
CompletedNCT03039036Updated Apr 3, 2023

Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction

An interventional study of Amniotomy and Foley Catheter in Labor Induction, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-03.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Amniotomy (breaking the bag of water) is commonly used in the induction of labor. However, the timing is highly variable. The purpose of this study is to determine if first time mothers undergoing induction of labor with a Foley catheter experience a decrease in their labor time when undergoing early amniotomy (breaking the bag of water within 1 hour of Foley catheter removal) than when undergoing delayed amniotomy (breaking the bag of water at least 4 hours after Foley catheter removal). Other aims include the relationship between timing of amniotomy and cesarean section, postpartum hemorrhage, intrauterine infection, neonatal Apgar score \<7 at 5 minutes, neonatal need for intensive care.

The investigators hypothesize that induction of labor with Foley catheters followed by early amniotomy will result in a decreased duration of labor compared to those who undergo delayed amniotomy.

Read the detailed description

This randomized clinical trial of consenting nulliparous women undergoing induction of labor with a Foley catheter seeks to determine whether use of early amniotomy (defined as amniotomy within 1 hour of Foley catheter removal) improves obstetrical outcomes when compared with delayed amniotomy (defined as amniotomy at least 4 hours following Foley catheter removal).

This project will include 110 women recruited from the obstetrical service at Prentice Women's Hospital. Women will be included if they are at least 37 weeks gestation, have a singleton pregnancy, have intact membranes and are undergoing an induction of labor using a Foley catheter. Following removal of Foley catheter, women will be assessed for safety of amniotomy and if appropriate, randomized to either early amniotomy or delayed amniotomy.

Women will be randomized with equal probability to the intervention group using block randomization stratified by use of Foley catheter alone or Foley catheter-misoprostol use.

Women in the early amniotomy group will undergo amniotomy within 1 hour of Foley catheter removal. Women in the delayed amniotomy group will undergo amniotomy at least 4 hours following Foley removal. The remainder of labor management will be at the discretion of each woman's obstetric provider.

Prior to discharge from the hospital, baseline demographic and clinical data will be obtained via chart review

02

Conditions studied

  • Labor Induction

Keywords

  • Labor Induction
  • Early Amniotomy
  • Foley catheter
03

In context

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Able to provide informed consent
  • English speaking
  • Women age 18 years old or greater
  • Nulliparous
  • Pregnant with a singleton gestation that is greater than or equal to 37 weeks
  • Undergoing induction of labor with Foley catheter

Exclusion criteria

Exclusion Criteria:

  • Women not meeting above criteria
  • Fetus in non-cephalic position
  • Intrauterine fetal demise
  • Fetus with major anomalies
  • HIV, hepatitis B or C infection
  • Planned use of oxytocin during the Foley catheter ripening
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
69 participants (actual)

Study arms

  • Experimental
    Early Amniotomy

    Patients undergoing induction of labor with foley catheter, with or without concurrent use of misoprostol, will undergo amniotomy within 1 hour of Foley catheter removal.

    Procedure: Amniotomy · Device: Foley Catheter · Drug: Misoprostol

  • Active comparator
    Delayed Amniotomy

    Patients undergoing induction of labor with foley catheter, with or without concurrent use of misoprostol, will undergo amniotomy no sooner than 4 hours following removal of Foley catheter.

    Procedure: Amniotomy · Device: Foley Catheter · Drug: Misoprostol

Interventions

  • ProcedureAmniotomy

    Artificially rupturing membranes

  • DeviceFoley Catheter

    Foley catheter device is commonly used for cervical ripening during labor induction. It is used independently or in combination with pharmacologic augmentation. It is inserted in the cervix and the balloon is then inflated with 60 cc of saline. It is removed when either 1. it falls out under gentile traction during labor checks or 2. it is de-inflated at 12 hours after placement. If at the time of de-inflation at 12 hours, the desired affect has not been achieved, the provider may choose to place another foley balloon or use an alternative method of induction (misoprostol). This is an eligibility criteria and only patients who are undergoing induction with a Foley Catheter will be approached for enrollment.

  • DrugMisoprostol

    Misoprostol is a medication that is commonly used for cervical ripening during labor induction. It is commonly used independently or in combination with mechanical methods, such as a foley catheter. The commonly used dose during term labor induction is 25 mcg. Use of this medication will be decided by the provider.

06

What researchers measure

Primary outcomes

  1. Time interval from Foley catheter removal to delivery

    Hours

    Time frame: Number of hours from removal of Foley catheter to delivery of neonate; up to 72 hours.

Secondary outcomes

  1. Cesarean delivery

    binary; yes/no

    Time frame: At time of delivery

  2. Chorioamnionitis

    Maternal Temperature of \>/= 39 degrees Celsius or \>/= 38 degrees Celsius on two occasions greater than 30 minutes apart and at least one of the following: Fetal tachycardia (defined as sustained (\>10 min) fetal heart rate \>160), White Bood Cell Count \>15, purulent fluid from cervical os, or receipt of antibiotics and diagnosis written in the chart

    Time frame: From time of admission to Labor and Delivery unit to delivery of neonate; up to 72 hours

  3. Postpartum Fever

    Temperature \>/= 38 degrees celsius on 2 separate occasions greater than 6 hours apart

    Time frame: From time of delivery to time of hospital discharge; up to 6 weeks

  4. Wound infection

    Cellulitis or erythema and induration around the incision and purulent discharge from the incision site with or without fever

    Time frame: From time of delivery to time of hospital discharge; up to 6 weeks

  5. Endometritis

    fundal tenderness and fever that required treatment with antibiotics

    Time frame: From time of delivery to time of hospital discharge; up to 6 weeks

  6. 5 minute Apgar Score less than 7 out of 10

    Neonatal Apgar scores consist of measurements of neonatal skin color, respiratory rate, heart rate, muscle tone, and irritability. Each parameter is given a score of 0, 1 or 2 based on standardized parameters. It is standard to perform this on all neonates at 1 minute and 5 minutes of life. Apgar scores are performed and calculated by nursing staff or members of the pediatric team. For this outcome, we are interested in scores less than 7 out of 10 at 5 minutes of life.

    Time frame: 5 minutes following delivery; 5 minutes of neonatal life.

  7. Neonatal intensive care unit admission

    Admission to the neonatal intensive care unit for greater than 24 hours

    Time frame: From time of delivery to hospital discharge; up to 6 weeks

  8. Length of Labor

    hours

    Time frame: Time from placement of Foley catheter to time of delivery of neonate; up to 5 days

  9. Suspected or confirmed neonatal sepsis

    As clinical suspected by the neonatology team or with positive cultures

    Time frame: From time of delivery to hospital discharge; up to 6 weeks

  10. Postpartum hemorrhage

    Delivery estimated blood loss of \> 500 cc for vaginal delivery or \> 1000 cc for cesarean delivery

    Time frame: From time of delivery to time of hospital discharge; up to 6 weeks

  11. Delivery time less than 24 hours

    binary; yes/no

    Time frame: From time of placement of Foley catheter to time of delivery of neonate; within 24 hours.

07

Study locations

1 site
  • Prentice Women's Hospital
    Chicago, Illinois 60611, United States
08

References and documents

Publications

  • Osterman MJ, Martin JA. Recent declines in induction of labor by gestational age. NCHS Data Brief. 2014 Jun;(155):1-8. PubMed 24941926 ↗
  • Maslow AS, Sweeny AL. Elective induction of labor as a risk factor for cesarean delivery among low-risk women at term. Obstet Gynecol. 2000 Jun;95(6 Pt 1):917-22. doi: 10.1016/s0029-7844(00)00794-8. PubMed 10831992 ↗
  • Garcia-Simon R, Montanes A, Clemente J, Del Pino MD, Romero MA, Fabre E, Oros D. Economic implications of labor induction. Int J Gynaecol Obstet. 2016 Apr;133(1):112-5. doi: 10.1016/j.ijgo.2015.08.022. Epub 2015 Dec 18. PubMed 26868065 ↗
  • Carbone JF, Tuuli MG, Fogertey PJ, Roehl KA, Macones GA. Combination of Foley bulb and vaginal misoprostol compared with vaginal misoprostol alone for cervical ripening and labor induction: a randomized controlled trial. Obstet Gynecol. 2013 Feb;121(2 Pt 1):247-252. doi: 10.1097/AOG.0b013e31827e5dca. PubMed 23303106 ↗
  • Smyth RM, Markham C, Dowswell T. Amniotomy for shortening spontaneous labour. Cochrane Database Syst Rev. 2013 Jun 18;2013(6):CD006167. doi: 10.1002/14651858.CD006167.pub4. PubMed 23780653 ↗
  • Gelber S, Sciscione A. Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol. 2006 Sep;49(3):642-57. doi: 10.1097/00003081-200609000-00022. PubMed 16885669 ↗
  • Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. doi: 10.1002/14651858.CD001233.pub2. PubMed 22419277 ↗
  • Mizrachi Y, Levy M, Bar J, Kovo M. Induction of labor in nulliparous women with unfavorable cervix: a comparison of Foley catheter and vaginal prostaglandin E2. Arch Gynecol Obstet. 2016 Oct;294(4):725-30. doi: 10.1007/s00404-016-4026-9. Epub 2016 Feb 2. PubMed 26837386 ↗
  • Levy R, Ferber A, Ben-Arie A, Paz B, Hazan Y, Blickstein I, Hagay ZJ. A randomised comparison of early versus late amniotomy following cervical ripening with a Foley catheter. BJOG. 2002 Feb;109(2):168-72. doi: 10.1111/j.1471-0528.2002.01137.x. PubMed 11888099 ↗
  • Battarbee AN, Palatnik A, Peress DA, Grobman WA. Association of Early Amniotomy After Foley Balloon Catheter Ripening and Duration of Nulliparous Labor Induction. Obstet Gynecol. 2016 Sep;128(3):592-597. doi: 10.1097/AOG.0000000000001563. PubMed 27500341 ↗
  • Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 Dec;128(6):1357-1364. doi: 10.1097/AOG.0000000000001778. PubMed 27824758 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03039036
Lead sponsor
Northwestern University
Responsible party
Emily Miller (Assistant Professor of Obstetrics and Gynecology, Northwestern University) — Principal investigator
First posted
Feb 1, 2017
Start date
Sep 12, 2017
Primary completion
Dec 1, 2022
Completion
Dec 1, 2022
Last update
Apr 3, 2023

Study contacts

Emily Miller, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion